Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.
Bertolino A, Caforio G, Blasi G, De Candia M, Latorre V, Petruzzella V, Altamura M, Nappi G, Papa S, Callicott JH, Mattay VS, Bellomo A, Scarabino T, Weinberger DR, Nardini M. Bertolino A, et al. Among authors: de candia m. Am J Psychiatry. 2004 Oct;161(10):1798-805. doi: 10.1176/ajp.161.10.1798. Am J Psychiatry. 2004. PMID: 15465976 Clinical Trial.
Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder.
De Candia MP, Di Sciascio G, Durbano F, Mencacci C, Rubiera M, Aguglia E, Garavini A, Bersani G, Di Sotto A, Placidi G, Cesana BM. De Candia MP, et al. Clin Ther. 2009 Dec;31(12):2851-9. doi: 10.1016/j.clinthera.2009.12.010. Clin Ther. 2009. PMID: 20110024 Clinical Trial.
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases.
Carrieri A, Barbarossa A, de Candia M, Samarelli F, Damiano Altomare C, Czarnota-Łydka K, Sudoł-Tałaj S, Latacz G, Handzlik J, Brunetti L, Piemontese L, Limongelli F, Lentini G, Carocci A. Carrieri A, et al. Among authors: de candia m. Bioorg Med Chem. 2024 Aug 1;110:117829. doi: 10.1016/j.bmc.2024.117829. Epub 2024 Jul 3. Bioorg Med Chem. 2024. PMID: 39002183 Free article. Review.
Nature-Inspired 1-Phenylpyrrolo[2,1-a]isoquinoline Scaffold for Novel Antiproliferative Agents Circumventing P-Glycoprotein-Dependent Multidrug Resistance.
Nevskaya AA, Purgatorio R, Borisova TN, Varlamov AV, Anikina LV, Obydennik AY, Nevskaya EY, Niso M, Colabufo NA, Carrieri A, Catto M, de Candia M, Voskressensky LG, Altomare CD. Nevskaya AA, et al. Among authors: de candia m. Pharmaceuticals (Basel). 2024 Apr 22;17(4):539. doi: 10.3390/ph17040539. Pharmaceuticals (Basel). 2024. PMID: 38675499 Free PMC article.
Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults.
Samarelli F, Purgatorio R, Lopopolo G, Deruvo C, Catto M, Andresini M, Carrieri A, Nicolotti O, De Palma A, Miniero DV, de Candia M, Altomare CD. Samarelli F, et al. Among authors: de candia m. Eur J Med Chem. 2024 Apr 15;270:116353. doi: 10.1016/j.ejmech.2024.116353. Epub 2024 Mar 20. Eur J Med Chem. 2024. PMID: 38579622 Free article.
92 results